chevron_leftBack
As of 21 June 2026, Apex Biotechnology Corp. has a market cap of $90.72M USD, ranking #26252 globally and #1457 in Taiwan.
It ranks #2353 in the Healthcare sector, and #453 in the Biotechnology industry.
Key Stats
Market Cap
$90.72MUSD
2.87B TWD
Enterprise Value
$73.79MUSD
2.33B TWD
Revenue (TTM)
$61.51MUSD
1.94B TWD
EBITDA (TTM)
$6.03MUSD
190.92M TWD
Net Income (TTM)
$5.15MUSD
162.89M TWD
EBITDA Margin
9.8%
Profit Margin
8.4%
PE Ratio
17.7
PS Ratio
1.5
PB Ratio
1.5
EV/EBITDA
11.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Yanshi Shen
open_in_new
Founded
1997
Website
apexbio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.5% | -2.9% | -4.2% | -4.8% | -16% | -10% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
1733
五鼎生物技術股份有限公司
ISIN: TW0001733004
Shares Out.:
Shares Outstanding:
99.95M1
Shares Float:
90.12M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
28.55 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Apex Biotechnology Corp.
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is based in Hsinchu City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
6K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
2K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
1K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
701%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
562%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
530%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
201K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
176K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
52K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
49K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
47K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
46K%
33.71B CHF
|
37.2
|
chevron_leftBack